Hyderabad-based biotech company working on developing a nasal vaccine for COVID-19
NATIONAL | April 5, 2020:
An international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies FluGen along with Bharat Biotech has begun the development and testing of a vaccine against COVID-19 called CoroFlu.
Bharat Biotech will manufacture the vaccine, conduct clinical trials, and prepare to produce almost 300 million doses of vaccine for global distribution.
Under the collaboration agreement, FluGen will transfer its existing manufacturing processes to Bharat Biotech to enable the company to scale up production and produce the vaccine for clinical trials," Dr. Raches Ella, Head of Business Development, Bharat Biotech said.
AIR
